VHPB Centre for Evaluation of Vaccination (CEV) |
Executive Secretary Administrative and Scientific Secretariat |
privacy statement
|
Budapest, Hungary, March 18-19, 2010
Thursday, March 18, 2010
Session 1 Introduction
Chair: David Goldberg, Mark Kane
08.30 - 09.00
Session 2 Screening for persons with underlying chronic disease
09.00 – 09.30
Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years. 518Kb (.pdf)
Anne Andermann
Lessons learnt from other screening programmes
09.30 – 09.50
HIV 345Kb (.pdf)
Caroline Semaille-Safar
09.30 – 09.50
Screening for Chronic Kidney disease: Where does Europe go?. 955Kb (.pdf)
Paul E de jong
10.10 – 10.20 Discussion
10.20 – 10.40 Coffee Break
Chair: John Ward, Helène Norder
10.40 – 11.00
Results of a literature study on hepatitis screening in Europe
Mika Salminen (ECDC)
11.00 – 11.20
Long-term effectiveness and cost-effectiveness of screening for hepatitis C virus infection 426Kb (.pdf)
Gaby Sroczynski
11.20 – 11.30 Discussion
Session 3 Global burden of disease
11.30 – 11.50
Burden of disease of viral hepatitis 776Kb (.pdf)
Steven Wiersma (WHO)
11.50 – 12.10
Surveillance data and case definitions to define the burden of disease in Europe 545Kb (.pdf)
David Mercer (WHO-Europe)
12.10 – 12.20 Discussion
12.20 – 13.40 Lunch
Session 4 Ongoing activities to raise awereness and gather information about chronic viral hepatitis and organizations' vision on screening
Chair: Johannes Hallauer, Daniel Lavanchy
13.40 – 13.55
Institute of Medicine (IOM) 820Kb (.pdf)
Brian Mc Mahon
13.55 – 14.10
ECDC
Marita van de Laar
14.10 –14.25
EASL 1,7Mb (.pdf)
Heiner Wedemeyer
14.25 – 14.40
ELPA 743Kb (.pdf)
Nadine Piorkowsky
14.40 – 14.55
SOTA 431Kb (.pdf)
Nadine Piorkowsky
14.55 – 15.10
WHO 420Kb (.pdf)
Steven Wiersma
15.10 – 15.25 Discussion
15.25 – 15.45 Coffee Break
Session 5 Management of identified persons with chronic viral hepatitis
Chair: Daniel Shouval, Marinho Rui Tato
15.45 – 16.05
Update on treatment for hepatitis B and C. 1.3Mb (.pdf)
Heiner Wedemeyer
16.05 –16.25
Recommendations regarding viral hepatitis care and treatment. Whome to treat - When to treat? 868Kb (.pdf)
Geoffrey Dusheiko
16.25 – 16.45
Need for long term evaluation of therapy 469Kb (.pdf)
Solko Schalm
16.45 – 17.05
Economics of chronic hepatitis B and hepatitis C 487Kb (.pdf)
John Wong
17.05 – 17.20 Discussion
17.20 End of the Day
Friday, March 19, 2010
Session 6 Country Sessions
Chair: Steven Wiersma, Vana Papaevangelou
09.00 – 09.20
Migrant screening: challenges and options. 59Kb (.pdf)
Rowan Cody
09.20 – 09.40
Alaska. 623Kb (pdf)
Brian McMahon
09.40 – 10.00
Belgium 200Kb (.pdf)
Isabelle Colle (BASL)
10.00 – 10.20
France 793Kb (.pdf)
Francoise Roudot-Thoraval
10.20 – 10.40
Italy 585Kb (.pdf)
Daniele Prati
10.40 – 11.00 Coffee break
Chair: Hans Blystad, Alessandro Zanetti
11.00 – 11.20
Scotland 303Kb (.pdf)
David Goldberg
11.20 – 11.40
UK 119Kb (.pdf)
William Irving
11.40 – 12.00
USA 908Kb (.pdf)
Geoff Beckett (CDC)
12.00 – 12.20
Russia 463 Kb (.pdf)
Vladimir Chulanov
12.20 – 12.40
the Netherlands 197 Kb (.pdf)
Irene Veldhuijzen
12.40 – 12.50 Discussion
12.50 – 14.15 Lunch
Session 7 Conclusions of the meeting
Chair: Pierre Van Damme, Francoise Roudot Thorval
14.15 – 15.15
Presentation of the VHPB meeting conclusions 86Kb (.pdf)
D. FitzSimons
15.15 End of the meeting